GPT and cancer: There are two recognized telomere maintenance mechanisms (TMMs) in cancer: telomerase activation, which is known to exist in 85–90% of malignancies [3, 4], and a homologous recombination-based process called alternative lengthening of telomeres (ALT) [5].